Skip to main navigation Skip to search Skip to main content

Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer

  • M Mackean
  • , AST Planting
  • , C Twelves
  • , JHM (Jan) Schellens
  • , D Allman
  • , B Osterwalder
  • , B Reigner
  • , T Griffin
  • , SB Kaye
  • , Jaap Verweij

Research output: Contribution to journal › Article › Academic › peer-review

260 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)2977-2985
Number of pages9
JournalJournal of Clinical Oncology
Volume16
Issue number9
Publication statusPublished - 1998

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research programs

  • EMC 04-01-DD-08-01

Cite this